These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4310914)

  • 1. Effect of aldosterone on angiotensin-induced glycosuria.
    Hori S; Masumura S; Ono K
    Mie Med J; 1969 May; 19(1):61-6. PubMed ID: 4310914
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of angiotensin-induce glycosuria.
    Hori S; Masumura S; Ono K; Sato Y
    Mie Med J; 1969 May; 19(1):67-73. PubMed ID: 4310915
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on angiotensin-induced glycosuria.
    Hors ; Masumura S; Ono K
    Mie Med J; 1969 May; 19(1):53-9. PubMed ID: 4310913
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of spironolactone administration on plasma and urinary aldosterone in man and the rat.
    Vallotton MB; Riondel AM; Gaillard R; Guelpa-Decorzant C
    Prog Biochem Pharmacol; 1980; 17():58-65. PubMed ID: 6259661
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
    Wisgerhof M
    J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of renin by human kidney slices, in vitro effect of angiotensin II, norepinephrine and aldosterone.
    Rosset E; Veyrat R
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):792-4. PubMed ID: 4331508
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist.
    Van Belle E; Bauters C; Wernert N; Hamon M; McFadden EP; Racadot A; Dupuis B; Lablanche JM; Bertrand ME
    Cardiovasc Res; 1995 Jan; 29(1):27-32. PubMed ID: 7895235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary excretion of aldosterone in experimental saturnism].
    Altamura B; Chiantera A; Lostorto A; De Salvia F; L'Abbate N; Musti M
    Med Lav; 1971 Oct; 62(10):472-7. PubMed ID: 4336327
    [No Abstract]   [Full Text] [Related]  

  • 13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of the action of angiotensin on the kidney].
    Jahn H; Reville P; Kurtz T; Kuntzmann F; Stahl J
    Pathol Biol; 1967; 15(11):641-8. PubMed ID: 4292970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Direct action of mineralocorticoid antagonists on biosynthesis of aldosterone: comparative activities of several new compounds].
    Netchitailo P; Perroteau I; Delarue C; Leboulenger F; Capron MH; Vaudry H
    Can J Physiol Pharmacol; 1983 Jan; 61(1):23-8. PubMed ID: 6301660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aldosterone on renin release in the isolated bloodless perfused canine kidney.
    Greco JM; Murphy GP
    Invest Urol; 1972 Jan; 9(4):294-9. PubMed ID: 5058768
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.
    Li X; Meng Y; Wu P; Zhang Z; Yang X
    Regul Pept; 2007 Jan; 138(1):15-25. PubMed ID: 16971004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
    Henger A; Tutt P; Riesen WF; Hulter HN; Krapf R
    J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.